SEC Form 4/A · accession 0001179110-16-028936
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Paul A Friedman
Officer — Chief Executive Officer · Director
Period of report
Jul 22, 2016
Accepted (ET)
Aug 23, 2016 · 3:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 22, 2016 | A | 153,128 | $0.00 | A | 153,274 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $9.45 | Jul 22, 2016 | A | 306,256 | A | Jul 22, 2016 | Jul 22, 2026 | Common Stock | 306,256 | 306,256 | D |
Explanation of responses
- F1The original report incorrectly identified that the reporting person acquired 143,557 shares of common stock. This report amends the original report to reflect the correct number of shares acquired by the reporting person.
- F2The original report incorrectly identified that the reporting person acquired 287,115 employee stock options. This report amends the original report to reflect the correct number of employee stock options acquired by the reporting person.